Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Post by antoninuson Jun 23, 2010 3:20pm
319 Views
Post# 17215451

so let me see

so let me seethe fda cancels the meeting, and gives no reason to lux other than to say that they need clarification on certain outstanding issues, but they dont say which issues..and they may not until the actual day of the meeting? is this normal behaviour from the FDA? you would think they would want to help facilitate a drugs approval given its unmet need in the market that could allevaite many peoples suffering...that doesn`t mean push it through, but it does mean, if you have to cancel because you need more data, then be specific about the data you need IN ADVANCE of the aug 3rd meeting. 

Personally speaking, I think it stinks...  something is rotten in denmark. 
<< Previous
Bullboard Posts
Next >>